Empagliflozin as a Treatment for Severe Congenital Neutropenia Due to G6PC3 Deficiency

Clinical trial NCT05078879 · COMPLETED

Trial details

NCT number: NCT05078879
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Crohn's Disease Glycogen Metabolism Inflammatory Bowel Disease (IBD)

Start date: 2021-11-16
Primary completion: 2025-05-02
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.